The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
C13H12FeN2O, monoclinic, P21/n (no. 14), a = 5.9035(2) Å, b = 20.7111(6) Å, c = 9.1403(3) Å, β = 90.0762(16)°, V = 1117.57(6) Å3, Z = 4, Rgt(F) = 0.0282, wRref(F2) = 0.0656, T = 150(2) K.
Main Authors: | Škoch Karel, Císařová Ivana, Štěpnička Petr |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2017-07-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Subjects: | |
Online Access: | https://doi.org/10.1515/ncrs-2017-0015 |
Similar Items
-
The crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κS:κS,κS′)] bis[1′-(diphenylphosphino-κP)-1-cyanoferrocene]disilver(I), C56H56Ag2Fe2N4P2S4
by: Škoch Karel, et al.
Published: (2019-09-01) -
Ferrocenes : ligands, materials and biomolecules /
by: 294671 Stepnicka, Petr
Published: (2008) -
2-[(Ferrocen-1-yl)(hydroxy)methyl]prop-2-enenitrile
by: R. Raghunathan, et al.
Published: (2013-12-01) -
[6-(Hydroxymethyl)pyridin-2-yl]methyl ferrocene-1-carboxylate
by: Mathieu Auzias, et al.
Published: (2011-11-01) -
Synthesis of new 3-(4-methyl-2-arylthiazol-5-yl)-5-aryl-1,2,4-oxadiazole derivatives as potential cytotoxic and antimicrobial agents
by: Abdul Latif N. Shaikh, et al.
Published: (2022-12-01)